Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01619488 · ClinicalTrials.gov registry record · NA

Laparoscopic Adjustable Gastric Banding in Adolescents

A NA study of Morbid Obesity, sponsored by Kirk Reichard.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT01619488: Completed NA study of Morbid Obesity, sponsored by Kirk Reichard.

NCT01619488 is a NA study of Morbid Obesity that has completed, run by Kirk Reichard. The registered enrollment target is 57 participants, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01619488, a NA study of Morbid Obesity, has completed, sponsored by Kirk Reichard.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

This study is to determine if the Lap-band system is safe and effective for use in morbidly obese adolescents.

Primary Outcome

Weight loss in kilograms Weight on day of surgery minus last weight recorded before end of trial

Conditions Studied

Interventions

  • DEVICE Adjustable Gastric Band

Study Locations (1)

Delaware

  • A I duPont Hospital for Children/Nemours Children's Clinic - Wilmington

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2007-04-23
Est. Completion 2016-04-04
Phase NA
Kirk Reichard

1 total trials

What the finished NCT01619488 record still lists

NCT01619488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which Adjustable Gastric Band is the first listed.

NCT01619488 reports a single indexed study location in Delaware.

Frequently Asked Questions

What is clinical trial NCT01619488 about?

NCT01619488 is a clinical study titled "Laparoscopic Adjustable Gastric Banding in Adolescents". This study is to determine if the Lap-band system is safe and effective for use in morbidly obese adolescents.

What is the current status of trial NCT01619488?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2007-04-23. Estimated completion is 2016-04-04.

What conditions does trial NCT01619488 study?

This clinical trial studies the following conditions: Morbid Obesity.

What interventions are being tested in trial NCT01619488?

The interventions under investigation include: Adjustable Gastric Band (DEVICE).

Who is sponsoring clinical trial NCT01619488?

This trial is sponsored by Kirk Reichard, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01619488 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Morbid Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01619488's enrollment target sits among peer trials

57 18th of 24 higher than 7 of 24 other Morbid Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01619488, the US trial registry maintained by the National Library of Medicine. NCT01619488 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.